Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions

被引：28

作者：

Zhang, Yiyin ^{[1
,2
,3
,4
]}

Yang, Chao ^{[1
,2
,3
,4
]}

Cheng, He ^{[1
,2
,3
,4
]}

Fan, Zhiyao ^{[1
,2
,3
,4
]}

Huang, Qiuyi ^{[1
,2
,3
,4
]}

Lu, Yu ^{[1
,2
,3
,4
]}

Fan, Kun ^{[1
,2
,3
,4
]}

Luo, Guopei ^{[1
,2
,3
,4
]}

Jin, Kaizhou ^{[1
,2
,3
,4
]}

Wang, Zhengshi ^{[1
,2
,3
,4
]}

Liu, Chen ^{[1
,2
,3
,4
]}

Yu, Xianjun ^{[1
,2
,3
,4
]}

机构：

[1] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, 270 DongAn Rd, Shanghai 200032, Peoples R China

[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, 270 DongAn Rd, Shanghai 200032, Peoples R China

[3] Shanghai Pancreat Canc Inst, 270 DongAn Rd, Shanghai 200032, Peoples R China

[4] Fudan Univ, Pancreat Canc Inst, 270 DongAn Rd, Shanghai 200032, Peoples R China

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2018年 / 11卷

基金：

中国国家自然科学基金;

关键词：

Pancreatic ductal adenocarcinoma; Novel regimens; Biomarkers; Combination therapies; GEMCITABINE PLUS PLACEBO; PHASE-II TRIAL; ALGENPANTUCEL-L IMMUNOTHERAPY; STANDARD ADJUVANT THERAPY; DOUBLE-BLIND; MESENCHYMAL TRANSITION; E-CADHERIN; RESECTABLE ADENOCARCINOMA; PREOPERATIVE GEMCITABINE; IONIZING-RADIATION;

D O I：

10.1186/s13045-017-0551-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A poor prognosis of pancreatic ductal adenocarcinoma (PDAC) associated with chemoresistance has not changed for the past three decades. A multidisciplinary diagnosis followed by surgery and chemo(radiation) therapy is the main treatment approach. However, gemcitabine-and 5-fluorouracil-based therapies did not present satisfying outcomes. Novel regimens targeting pancreatic cancer cells, the tumor microenvironment, and immunosuppression are emerging. Biomarkers concerning the treatment outcome and patient selection are being discovered in preclinical or clinical studies. Combination therapies of classic chemotherapeutic drugs and novel agents or novel therapeutic combinations might bring hope to the dismal prognosis for PDAC patients.

引用

页数：17

共 50 条

[1] Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
Yiyin Zhang
Chao Yang
He Cheng
Zhiyao Fan
Qiuyi Huang
Yu Lu
Kun Fan
Guopei Luo
Kaizhou Jin
Zhengshi Wang
Chen Liu
Xianjun Yu
Journal of Hematology & Oncology, 11
[2] Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma
Al Haddad, Amal H. I.
Adrian, Thomas E.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (11) : 1499 - 1515
[3] State of the art and future directions of pancreatic ductal adenocarcinoma therapy
Neuzillet, Cindy
Tijeras-Raballand, Annemilai
Bourget, Philippe
Cros, Jerome
Couvelard, Anne
Sauvanet, Alain
Vullierme, Marie-Pierre
Tournigand, Christophe
Hammel, Pascal
PHARMACOLOGY & THERAPEUTICS, 2015, 155 : 80 - 104
[4] The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
Cameron J. Herting
Isaac Karpovsky
Gregory B. Lesinski
Cancer and Metastasis Reviews, 2021, 40 : 675 - 689
[5] The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
Herting, Cameron J.
Karpovsky, Isaac
Lesinski, Gregory B.
CANCER AND METASTASIS REVIEWS, 2021, 40 (03) : 675 - 689
[6] Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions
Bandi, Dhana Sekhar Reddy
Sarvesh, Sujith
Farran, Batoul
Nagaraju, Ganji Purnachandra
El-Rayes, Bassel F.
CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 71 : 26 - 39
[7] Novel Therapeutics for Pancreatic Adenocarcinoma
Lowery, Maeve A.
O'Reilly, Eileen M.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (04) : 777 - +
[8] Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
Christenson, Eric S.
Jaffee, Elizabeth
Azad, Nilofer S.
LANCET ONCOLOGY, 2020, 21 (03): : E135 - E145
[9] A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
Ocal, Ozhan
Pashkov, Victor
Kollipara, Rahul K.
Zolghadri, Yalda
Cruz, Victoria H.
Hale, Michael A.
Heath, Blake R.
Artyukhin, Alex B.
Christie, Alana L.
Tsoulfas, Pantelis
Lorens, James B.
Swift, Galvin H.
Brekken, Rolf A.
Wilkie, Thomas M.
DISEASE MODELS & MECHANISMS, 2015, 8 (10) : 1201 - 1211
[10] Rapid in vivo screen of pancreatic ductal adenocarcinoma therapeutics
Ocal, Ozhan
Heath, Blake
Rivera, Lee B.
Pashkov, Victor
Swift, Galvin H.
Brekken, Rolf A.
Wilkie, Tom M.
MOLECULAR CANCER RESEARCH, 2014, 12

← 1 2 3 4 5 →